Press release
Advanced Genomics and Transcriptomics Sequencing Services Market to Reach USD 1,740.1 Million by 2036, Driven by Outsourced Research Workflows and Precision Medicine Demand
Advanced Genomics and Transcriptomics Sequencing Services Market
Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=15613
Key Market Highlights at a Glance
• Market value in 2025: USD 660.9 million
• Market size in 2026: USD 721.7 million
• Forecast market size in 2036: USD 1,740.1 million
• CAGR (2026-2036): 9.2%
• Absolute opportunity by 2036: USD 1,018.4 million
• Leading service type: Whole Genome Sequencing (25.0% share)
• Leading technology: Next-Generation Sequencing (NGS) (25.0% share)
• Leading application: Biomarker Discovery (25.0% share)
• Leading end user: Pharmaceutical & Biotechnology Companies (30.0% share)
Why Is the Advanced Genomics and Transcriptomics Sequencing Services Market Growing?
Key growth drivers include:
• Expansion of population-scale genome programs requiring sequencing, sample management, and secure data handling
• Rising adoption of long-read sequencing and full-length RNA analysis for structural variant detection
• Growing demand for single-cell, spatial transcriptomics, and biomarker discovery services in drug development
According to Shambhu Nath Jha, Senior Analyst at Fact.MR, "Competition in advanced genomics and transcriptomics services now depends more on clear and reliable results than on access to sequencing alone. Providers that plan studies, protect sample quality, and deliver comprehensive scientific analysis are positioned for stronger long-term adoption."
Which Service Type Leads Market Share?
Whole Genome Sequencing is expected to capture 25.0% of market demand in 2026.
The segment leads because it enables comprehensive detection of single-nucleotide variants, copy-number changes, structural alterations, and population-level genomic differences within a single workflow. Growing pangenome initiatives and ancestry-inclusive genomic research further strengthen adoption.
• Whole Genome Sequencing share (2026): 25.0%
• Supports rare disease and population genomics studies
• Enables broad variant coverage in one assay
Gain Full Access to Market Forecasts and Key Drivers: https://www.factmr.com/report/advanced-genomics-and-transcriptomics-sequencing-services-market
Why Does Next-Generation Sequencing Lead Technology Demand?
Next-Generation Sequencing (NGS) is projected to represent 25.0% of technology demand in 2026.
NGS remains the preferred platform because it supports genome, exome, targeted panel, and transcriptome applications while offering scalable
throughput and established analytical workflows.
• NGS market share (2026): 25.0%
• Widely used across genomics and transcriptomics workflows
• Supports predictable throughput and reproducible results
Which Applications and End Users Dominate Demand?
Biomarker Discovery is forecast to account for 25.0% of application demand in 2026.
Biomarker identification increasingly relies on genomic and transcriptomic comparisons across patient cohorts, disease states, and treatment responses.
Pharmaceutical & Biotechnology Companies are expected to command 30.0% of end-user demand in 2026.
• Biomarker Discovery share: 25.0%
• Pharmaceutical & Biotechnology Companies share: 30.0%
• Strong demand from target discovery and clinical trial support programs
Market Dynamics
Drivers
• Population-scale whole-genome reference programs
• Long-read structural and isoform resolution projects
• Single-cell and spatial transcriptomic mapping
• Multi-omics integration initiatives
• Pharmaceutical biomarker development demand
Restraints
• Batch effects and reproducibility challenges
• Sample scarcity in single-cell studies
• Chain-of-custody and compliance requirements
• Bioinformatics staffing and infrastructure gaps
Trends
• Multi-omics integration platforms
• Federated data interoperability standards
• Precision medicine and pharmacogenomic panels
• Clinical-grade quality system certification
Unlock 360° insights for strategic decision making and investment planning: https://www.factmr.com/checkout/15613
Regional and Country Outlook
Country CAGR projections:
• Germany: 12.4%
• Brazil: 11.5%
• USA: 10.6%
• South Korea: 9.7%
• United Kingdom: 8.7%
• Japan: 7.8%
Germany leads growth due to major genome programs, university hospital networks, and multinational research collaborations requiring secure genomic data exchange.
Brazil benefits from population diversity and expanding genomic initiatives, increasing demand for long-read sequencing and integrated interpretation services.
The United States continues to gain momentum through large-scale single-cell and tissue-mapping projects requiring extensive sequencing and bioinformatics support.
South Korea's growth is supported by hospital-driven multi-omics research and standardized study methodologies.
The United Kingdom and Japan remain important markets, driven respectively by biomarker research and carefully regulated clinical genomics programs.
Competitive Landscape
Key market participants include:
• Illumina, Inc. - leader in short-read sequencing platforms
• Eurofins Scientific SE - global laboratory services provider
• Revvity, Inc. - genomics and life science solutions specialist
• PacBio - high-accuracy long-read sequencing innovator
• Oxford Nanopore Technologies plc - real-time DNA and RNA sequencing
• Azenta Life Sciences - integrated sample and sequencing services
• BGI Genomics Co., Ltd. - large-scale genomics capabilities
• Novogene Co., Ltd. - global sequencing service network
Competition increasingly centers on workflow integration, sample quality management, advanced bioinformatics, and actionable scientific reporting rather than sequencing capacity alone.
Discover the Latest Insights in the Healthcare Industry: https://www.factmr.com/industry/healthcare
FAQ
What is the Advanced Genomics and Transcriptomics Sequencing Services Market worth in 2036?
The market is projected to reach USD 1,740.1 million by 2036.
What is the expected CAGR from 2026 to 2036?
The market is forecast to grow at a CAGR of 9.2% during the forecast period.
Which service type holds the largest share?
Whole Genome Sequencing leads the service type segment with a 25.0% share in 2026.
Which technology dominates the market?
Next-Generation Sequencing (NGS) holds the leading technology share at 25.0% in 2026.
Which application leads demand?
Biomarker Discovery is expected to account for 25.0% of application demand in 2026.
Which end-user segment is largest?
Pharmaceutical & Biotechnology Companies lead with a 30.0% market share in 2026.
Which country is growing the fastest?
Germany is the fastest-growing major market with a projected CAGR of 12.4% through 2036.
Top Trending Reports:
Advanced Bipolar Direct Energy Devices Market: https://www.factmr.com/report/advanced-bipolar-direct-energy-devices-market
Advanced Parenteral Drug Market: https://www.factmr.com/report/advanced-parenteral-drug-market
Advanced Ophthalmology Technologies Market: https://www.factmr.com/report/advanced-ophthalmology-technologies-market
Advanced Wound Dressing Market: https://www.factmr.com/report/advanced-wound-dressing-market
- Contact Us -
11140 Rockville Pike, Suite 400, Rockville,
MD 20852, United States
Tel: +1 (628) 251-1583 | sales@factmr.com
About Fact.MR
Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Advanced Genomics and Transcriptomics Sequencing Services Market to Reach USD 1,740.1 Million by 2036, Driven by Outsourced Research Workflows and Precision Medicine Demand here
News-ID: 4582193 • Views: …
More Releases from Fact.MR
Low-Solubility HPPs Market to Reach USD 284 Million by 2036, Growing at 5.3% CAG …
DPP Pigments and Automotive Coatings Lead Demand as Formulators Prioritize Migration Resistance and Long-Term Color Durability
New York, July 20, 2026 - The global Low-Solubility HPPs Market, valued at USD 169.0 million in 2026, is projected to reach USD 284.0 million by 2036, expanding at a steady 5.3% CAGR during the forecast period. This growth reflects rising demand for high-performance organic pigments that resist dissolution, bleeding, and migration in demanding applications…
Global Wet Pet Food Processing Equipment Market Set to Reach USD 3.3 Billion by …
Mixing Equipment to Hold 18% Product Segment Share in 2026, Hardware Systems Lead Component Segment with 52% Share, Mexico Fastest-Growing at 8.3% CAGR
New York- July 20, 2026 - The global wet pet food processing equipment market stood at USD 1.7 billion in 2025 and is estimated to reach USD 1.8 billion in 2026. It is projected to expand at a CAGR of 6.2% during 2026-2036, attaining a value of USD…
High-Oleocanthal Olive Extract Market to Reach USD 4.7 Billion by 2036, Growing …
NEW YORK, July 20, 2026 - The global high-oleocanthal olive extract market is projected to grow from USD 2.3 billion in 2026 to USD 4.7 billion by 2036, registering a robust CAGR of 7.4% during the forecast period. This expansion reflects surging demand for high-potency natural bioactive compounds with proven anti-inflammatory and therapeutic properties across nutraceutical, pharmaceutical, and functional food applications.
Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=13676
Key…
Global Bone and Joint Health Supplement Market to Reach USD 35.0 Billion by 2036 …
New York - July 20, 2026 - The global bone and joint health supplement market is estimated at USD 16.5 billion in 2026 and is projected to reach USD 35.0 billion by 2036, registering a robust CAGR of 7.8% during the forecast period. This growth reflects increasing consumer focus on preventive musculoskeletal health, driven by aging demographics, rising fitness participation, and innovation in convenient supplement formats.
Get detailed market forecasts, competitive…
More Releases for Sequencing
Sequencing Reagents Market Report 2024 - Sequencing Reagents Market Trends And S …
"The Business Research Company recently released a comprehensive report on the Global Sequencing Reagents Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Sequencing the Future: Next Generation Sequencing Market Projections (2023-2033)
The global Next-generation Sequencing Market was over 8.5 billion in 2022 and it is anticipated to grow at a CAGR of over 18.2% during the forecast period.
Market Outlook:
The Next Generation Sequencing (NGS) market is set for an extraordinary trajectory of growth and innovation from 2023 to 2033. This decade is poised to witness a paradigm shift in genomics and molecular biology, with NGS technologies playing a central role in reshaping…
Sequencing Reagents Market - Elevating Accuracy, Inspiring Discovery: Revolution …
Newark, New Castle, USA - new report, titled Sequencing Reagents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Sequencing Reagents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Sequencing Reagents market. The report offers an overview of the market, which…
Microbiome Sequencing Services Market By Technology (Sequencing By Synthesis (SB …
Microbiome are the group of microorganisms that grow on saliva, skin layers, conjunctiva, oral mucosa and the gastrointestinal tract. Microbiome sequencing is the study and analysis of microbes groups located outside and inside of the human body to gain knowledge about human microbes.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00004419/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
Baseclear B.V.
Clinical-Microbiomics A/S
Molzym GmbH & Co. Kg
Zymo Research Corp.
Rancho Biosciences
Microbiome Therapeutics, LLC.
Microbiome Insights Inc.
Openbiome
Resphera Biosciences, LLC.
Ubiome, Inc.
The report covers key developments…
Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Search4Research.com
Get Research Sample PDF at https://www.search4research.com/request-sample/113582/
Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,…
Metagenomic Sequencing Market Technology Outlook 2027 - 16s Rrna Sequencing, Sho …
Worldwide Metagenomic Sequencing Market Analysis to 2027 is a specialized and in-depth study of the Metagenomic Sequencing Industry with a focus on the global market trend. The report aims to provide an overview of global Metagenomic Sequencing Market with detailed market segmentation by product/application and geography. The global Metagenomic Sequencing Market is expected to witness high growth during the forecast period.
Metagenomics, is a field where genomic analysis of microbial DNA…
